佰泽医疗(02609)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02609 佰泽医疗

未开盘 09-01 16:08:12

3.060

-0.210

-6.42%

最高3.270	最低3.020	成交量848.76万
今开3.270	昨收3.270	日振幅7.65%
总市值40.33亿	流通市值40.33亿	总股本13.18亿
成交额2,631万	换手率0.64%	流通股本13.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02609","market":"HK","secType":"STK","nameCN":"佰泽医疗","latestPrice":3.06,"timestamp":1788250092179,"preClose":3.27,"halted":0,"volume":8487600,"delay":0,"changeRate":-0.06422018348623852,"floatShares":1318000000,"shares":1318000000,"eps":-0.012036864125704698,"marketStatus":"未开盘","change":-0.21,"latestTime":"09-01 16:08:12","open":3.27,"high":3.27,"low":3.02,"amount":26313246,"amplitude":0.076453,"askPrice":3.065,"askSize":12000,"bidPrice":3.06,"bidSize":106200,"shortable":3,"etf":0,"ttmEps":0.026377071594909714,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":3.27,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.965479,"lotSize":600,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02609/wiki","defaultTab":"wiki","newsList":[{"id":"2663077102","title":"朱红兵减持佰泽医疗(02609)183.96万股 每股作价约3.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077102","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077102?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:10","pubTimestamp":1788174624,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，8月27日，朱红兵减持佰泽医疗(02609)183.96万股，每股作价3.1612港元，总金额约为581.53万港元。减持后最新持股数目约为7856.34万股，最新持股比例为5.96%。本次交易涉及关联方：崔一帆、Shanghai Xukun Enterprise Management Co., Ltd.、Shanghai Xuxi Enterprise Management Partnership (Limited Partnership）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02609","EWH","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171022695","title":"佰泽医疗：崔一帆减持，好仓比例降至5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171022695","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171022695?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:41","pubTimestamp":1788169275,"startTime":"0","endTime":"0","summary":"根据披露，崔一帆于2026年8月27日以每股均价3.1612港元卖出佰泽医疗股份183.96万股，涉资约581.53万港元。此次减持前崔一帆持有佰泽医疗好仓8040.30万股，占比6.1%；减持后持股量为7856.34万股，好仓比例降至5.96%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165340418","title":"佰泽医疗：Shanghai Xukun Enterprise Management Co., Ltd.减持，好仓比例降至5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165340418","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165340418?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:32","pubTimestamp":1788168748,"startTime":"0","endTime":"0","summary":"Shanghai Xukun Enterprise Management Co., Ltd.于2026年8月27日以每股均价3.1612港元卖出佰泽医疗股份183.96万股，涉资约581.53万港元。Shanghai Xukun Enterprise Management Co., Ltd.此次减持前持有佰泽医疗好仓8040.30万股，占比6.1%；减持后持股量为7856.34万股，好仓比例降至5.96%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183405856","title":"佰泽医疗：Shanghai Xuxi Enterprise Management Partnership (Limited Partnership)减持，好仓比例降至5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183405856","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183405856?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:23","pubTimestamp":1788168211,"startTime":"0","endTime":"0","summary":"Shanghai Xuxi Enterprise Management Partnership (Limited Partnership)于2026年8月27日以每股均价3.1612港元卖出佰泽医疗股份183.96万股，涉资约581.53万港元。Shanghai Xuxi Enterprise Management Partnership (Limited Partnership)此次减持前持有佰泽医疗好仓8040.30万股，占比6.1%；减持后持股量为7856.34万股，好仓比例降至5.96%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663107802","title":"佰泽医疗（02609.HK）扭亏为盈 肿瘤全周期战略进入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2663107802","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663107802?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:50","pubTimestamp":1788162645,"startTime":"0","endTime":"0","summary":"经调整净利润约1850万元，同比增长96.8%；EBITDA约8105万元，同比大增86.0%。","market":"us","thumbnail":"https://img7.gelonghui.com/column/4.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/4.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6432608","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02609","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662932062","title":"佰泽医疗(02609.HK)首次实现半年度盈利 打造全域全周期健康管理体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2662932062","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662932062?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:07","pubTimestamp":1787915220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02609","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662614310","title":"佰泽医疗(02609)发布中期业绩 股东应占溢利1441.8万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662614310","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662614310?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:27","pubTimestamp":1787912861,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰泽医疗(02609)发布截至2026年6月30日止6个月中期业绩，收入5.85亿元(人民币，下同)，同比增长1.69%;股东应占溢利1441.8万元，去年同期亏损2762万元;每股基本盈利0.01元。公告称，截至2026年6月30日止六个月，集团收入同比增加约1.7%，主要由于业务经营稳定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175041288","title":"佰泽医疗2026年上半年营收5.85亿元，经调整净利润18.5百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175041288","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175041288?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:23","pubTimestamp":1787912625,"startTime":"0","endTime":"0","summary":"2026年上半年，佰泽医疗实现营收5.85亿元，同比增长1.7%。同期，经调整净利润18.5百万元，同比增长96.8%。报告期内，毛利约为1.09亿元，同比增长2.2%，毛利率约18.6%。报告期内，佰泽医疗的EBITDA达到81.1百万元，同比增长86.0%；经调整EBITDA同样为81.1百万元，同比增长10.6%，显示整体经营效率持续改善。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"佰泽医疗2026年上半年营收5.85亿元，经调整净利润18.5百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198475808","title":"佰泽医疗（02609）拟于8月28日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1198475808","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198475808?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:52","pubTimestamp":1787043125,"startTime":"0","endTime":"0","summary":"佰泽医疗集团（股票代码：02609）8月18日公告，公司董事会已定于2026年8月28日（星期五）召开会议，拟审议并通过本集团截至2026年6月30日止六个月的中期业绩，并处理其他事项。\n公告显示，董事会成员包括执行董事陈昊阳博士、吕超先生、徐旭女士、卢继忠先生及冯宇先生；独立非执行董事陈学良先生、刘爽女士及郭卫博士。\n公司提醒投资者关注相关会议结果及后续披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114703504","title":"佰泽医疗7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1114703504","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114703504?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:46","pubTimestamp":1785919603,"startTime":"0","endTime":"0","summary":"2026年8月5日，佰泽医疗(02609)发布截至2026年7月31日的股份变动月报表。\n公告显示，截至本报告期末，公司法定股本仍为5,000,000,000股普通股，面值每股0.00001美元，合共50,000美元。已发行股份在上月底与本月底均为1,318,466,823股，未见增减变动，库藏股份数量为0股。\n本月公司无新增股份发行、购回或注销记录，亦无行使或授出新增期权情况，整体股本结构保持稳定。公司表示，其已遵守香港联交所《上市规则》及其他适用法律法规。\n本次月报由执行董事陈昊阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106300716","title":"佰泽医疗（02609）调整公司秘书团队并获港交所豁免上市规则3.28及8.17条严格遵守","url":"https://stock-news.laohu8.com/highlight/detail?id=1106300716","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106300716?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:36","pubTimestamp":1784622980,"startTime":"0","endTime":"0","summary":"佰泽医疗7月21日公告称，原联席公司秘书、授权代表及法律程序文件代理人方希琳女士已呈辞，上述职务自2026年7月21日起生效。方女士确认其与董事会并无意见分歧，亦无任何与其辞任有关事宜需提请股东及联交所关注。由于姚先生目前不符合上市规则3.28附注1所列的公司秘书专业资格要求，公司已向联交所申请并获准豁免，在曾先生获任联席公司秘书之日起至2028年10月13日的期间内，姚先生可继续担任联席公司秘书。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653220355","title":"佰泽医疗(02609.HK)：曾俊豪获委任为联席公司秘书、授权代表及法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2653220355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653220355?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:34","pubTimestamp":1784622893,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02609","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650168830","title":"佰泽医疗遭Shanghai Xukun Enterprise Management Co., Ltd.减持500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650168830","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650168830?lang=zh_cn&edition=full","pubTime":"2026-07-12 15:33","pubTimestamp":1783841580,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，7月8日，Shanghai Xukun Enterprise Management Co．， Ltd．减持佰泽医疗（02609）500万股，每股作价2.9540港元，总金额为1477万港元。减持后最新持股数目约为9091.56万股，最新持股比例为6.89%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-12/doc-inihpucx7810354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182176","title":"Shanghai Xukun Enterprise Management Co., Ltd.减持佰泽医疗(02609.HK)500万股 每股作价约2.95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650182176?lang=zh_cn&edition=full","pubTime":"2026-07-10 19:12","pubTimestamp":1783681956,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100313118","title":"佰泽医疗更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1100313118","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100313118?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:19","pubTimestamp":1783329564,"startTime":"0","endTime":"0","summary":"佰泽医疗集团于2026年7月6日发布截至2026年6月30日的股份变动月报表。公告显示，公司本月注册股本未发生变动，法定注册资本为5,000,000,000股，面值每股0.00001美元，注册股本总额50,000美元，保持与上月一致。此外，当月并无股份期权或股权激励计划发生授予、行使或终止情形。公司确认已充分符合香港联交所相关公眾持股量要求。该月报表由公司执行董事陈昊阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647158161","title":"港股异动 | 佰泽医疗(02609.HK)跌超21% 上周迎来最后一批解禁潮 近期出现两笔大额存仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2647158161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647158161?lang=zh_cn&edition=full","pubTime":"2026-06-30 11:40","pubTimestamp":1782790838,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645410839","title":"佰泽医疗(02609)：采纳2026年股份奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2645410839","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645410839?lang=zh_cn&edition=full","pubTime":"2026-06-23 21:00","pubTimestamp":1782219642,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰泽医疗(02609)发布公告，本公司于2026年6月23日已采纳该计划。该计划仅以现有股份支付，并不涉及发行任何新股份。该计划自采纳日期起计为期十年有效，根据该计划可授予的奖励上限为2000万股股份。受托人将根据董事会之指示，按照计划规则及信托契据从二级市场购买股份，以满足奖励之行使。该计划的目的为(i)表彰若干合资格参与者的贡献，并为彼等提供额外激励以达成绩效目标，以期实现提升本公司价值的目标;及(ii)吸引合适人员以促进本集团的进一步发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643751094","title":"佰泽医疗(02609)：吕超获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2643751094","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643751094?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:35","pubTimestamp":1781609730,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰泽医疗(02609)发布公告，赵永凯先生(赵先生)因欲投入更多时间于其他业务，故并无膺选连任，并于股东周年大会结束后退任执行董事。随着赵先生退任，彼亦于股东周年大会结束后不再担任本公司就上市规则第3.05条而言的授权代表。董事会进一步宣布，陈昊阳博士已获委任为授权代表，自2026年6月16日起生效。经股东于股东周年大会上批准后，吕超先生获委任为执行董事，自2026年6月16日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1209","02609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642625847","title":"佰泽医疗(02609)存仓市值总计14.91亿港元 其中股东向中信证券经纪香港存入2.95亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642625847","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642625847?lang=zh_cn&edition=full","pubTime":"2026-06-12 08:13","pubTimestamp":1781223222,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月11日，佰泽医疗(02609)出现仓位异动，存仓市值总计14.91亿港元，占比22.39%。该公司股东将股票存入中信证券经纪香港2.95亿股，持股比例为22.39%。佰泽医疗截至2025年6月30日止六个月的中期业绩显示，收入5.75亿元(人民币，下同)，同比增加0.66%;股东应占亏损2762万元，同比扩大139.18%;每股基本亏损0.02元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","LU1720050803.USD","LU0405327148.USD","LU1064130708.USD","LU2289578879.USD","BK1147","BK1521","BK0188","BK0028","LU1997244956.HKD","LU1997245094.SGD","02609","LU0405327494.USD","LU1064131003.USD","BK0196","BK0276","LU2495084118.USD","06030","LU1997245177.USD","LU1794554557.SGD","LU1580142542.USD","LU1781817850.SGD","BK0012","BK1564","LU1328615791.USD","BK1209","BK0183","600030","LU1255011170.USD","BK1516","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156826816","title":"佰泽医疗5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1156826816","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156826816?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:47","pubTimestamp":1780476437,"startTime":"0","endTime":"0","summary":"佰泽医疗于2026年6月3日更新披露2026年5月股份变动月报表。报告显示，截至2026年5月31日，公司注册股本未发生变化，维持5,000,000,000股普通股，面值每股0.00001美元，注册股本总额为5万美元。本月已发行股份方面，截至4月底公司已发行普通股1,318,466,823股，无库藏股；经月度调整后，5月底的已发行股份数目维持在1,318,466,823股，公司无新增发行亦无回购注销或库藏股变动。公告由执行董事陈昊阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bayzedhealthcare.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.3793},{"period":"6month","weight":0.0132},{"period":"1year","weight":-0.5392},{"period":"ytd","weight":-0.199}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0118},{"period":"6month","weight":0.0003},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":-0.0117}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"佰泽医疗集团是一家主要从事投资及提供医疗相关服务的肿瘤医疗公司。该公司在肿瘤全周期医疗服务领域提供服务，包括筛查、诊断、治疗及康复。该公司主要从事医院业务、医院管理服务、供应药品、医疗设备及耗材及其他业务。该公司业务包括对患者开展肿瘤诊断、肿瘤治疗、肿瘤康复及临终关怀等，以及对其他潜在健康人群开展的早癌筛查、肿瘤疫苗接种、健康管理服务。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"佰泽医疗","nameEN":"BAYZED HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佰泽医疗(02609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佰泽医疗(02609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佰泽医疗,02609,佰泽医疗股票,佰泽医疗股票老虎,佰泽医疗股票老虎国际,佰泽医疗行情,佰泽医疗股票行情,佰泽医疗股价,佰泽医疗股市,佰泽医疗股票价格,佰泽医疗股票交易,佰泽医疗股票购买,佰泽医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佰泽医疗(02609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佰泽医疗(02609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}